Inflammatory Responses Completed Phase 4 Trials for Soybean oil (DB09422)

Also known as: Inflammatory Response

IndicationStatusPhase
DBCOND0062877 (Inflammatory Responses)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00600912Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic FunctionTreatment